ArticleFrontiers in oncology2022

Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer.

Kangni Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.